You have 9 free searches left this month | for more free features.

HA-2

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Recruiting
  • Neuroendocrine Tumors (NET)
  • 68Ga-HA-DOTATATE PET/CT imaging
  • Calgary, Alberta, Canada
    Foothills Medical Center 1403 29 St NW
Jan 4, 2023

Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

Active, not recruiting
  • Pulmonary Vascular Disease
  • +2 more
  • Assessment without intervention at High altitude
  • Relocation to sea level for 2 days
  • Zurich, Switzerland
    University Hospital Zurich
Oct 2, 2023

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Neuroendocrine Tumors Trial in Edmonton (68Ga-HA-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Edmonton, Alberta, Canada
    University of Alberta
Apr 11, 2022

Hip Osteoarthritis Trial in Winnipeg (Avenir cementless hip stem, Corail HA-coated hip stem)

Active, not recruiting
  • Hip Osteoarthritis
  • Avenir cementless hip stem
  • Corail HA-coated hip stem
  • Winnipeg, Manitoba, Canada
    Concordia Hospital
Sep 26, 2022

Aging Trial in Paris (injection, Cream application)

Completed
  • Aging
  • injection
  • Cream application
  • Paris, France
    Dr Jean-Jacques DEUTSCH
Nov 7, 2022

A Human Versus Machine Comparison Study

Recruiting
  • Head and Neck Cancer
    • Northwood, UK, United Kingdom
      East & North Hertfordshire NHS Trust
    Sep 15, 2023

    Neuroendocrine Tumors Trial in Edmonton (18F-DOPA with furosemide)

    Not yet recruiting
    • Neuroendocrine Tumors
    • 18F-DOPA with furosemide
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    May 23, 2022

    Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Sep 8, 2023

    Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)

    Completed
    • Healthy Volunteers (Diabetes Mellitus, Type 2)
    • Semaglutide B, 1.34 mg/mL
    • Semaglutide D, 1.0 mg/mL
    • Harrow, Middlesex, United Kingdom
      Novo Nordisk Investigational Site
    Jan 29, 2023

    The GOAL27-6 Study

    Recruiting
    • Head and Neck Cancer
      • Northwood, Middlesex, United Kingdom
        Mount Vernon Cancer Centre
      May 5, 2023

      Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

      Recruiting
      • Thyroid Eye Disease
      • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
      • +2 more
      • Boston, Massachusetts
        Mass Eye and Ear
      Feb 8, 2022

      COVID-19 Vaccines Trial in Ho Chi Minh City, Ha Noi (ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine, Placebo (normal saline),

      Active, not recruiting
      • COVID-19 Vaccines
      • ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine
      • +2 more
      • Ho Chi Minh City, Ho Chi Minh, Vietnam
      • +2 more
      Mar 14, 2022

      Neuroendocrine Tumors Trial in Edmonton ([68]Ga-HA-DOTATATE)

      Recruiting
      • Neuroendocrine Tumors
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Jun 18, 2021

      Chronic Pain, Pain, Chronic Trial in Nottingham (Pain at Work Toolkit, Active control)

      Not yet recruiting
      • Chronic Pain
      • Pain, Chronic
      • Pain at Work Toolkit
      • Active control
      • Nottingham, United Kingdom
        University of Nottingham
      Apr 28, 2023

      Healthy Volunteers - Liver Diseases Trial in Watford (NNC0560-0004, Placebo (NNC0560-0004))

      Recruiting
      • Healthy Volunteers - Liver Diseases
      • Watford, Middlesex, United Kingdom
        Novo Nordisk Investigational Site
      Nov 14, 2023

      Induction of Labor Trial in Hanoi (Double-balloon catheter (UTAH CVX-RIPE) for cervical ripening, Dinoprostone 10mg (Propess))

      Recruiting
      • Induction of Labor
      • Double-balloon catheter (UTAH CVX-RIPE) for cervical ripening
      • Dinoprostone 10mg (Propess)
      • Hanoi, Hà Nội, Vietnam
        Hanoi Obstetrics and Gynecology Hospital
      Aug 4, 2022

      Osteomyelitis, Prosthetic Joint Infection, Diabetic Foot Trial in Germany, Portugal, United Kingdom (Shorter Systemic

      Recruiting
      • Osteomyelitis
      • +2 more
      • Shorter Systemic Antibiotics
      • Standard treatment
      • Regensburg, Germany
      • +22 more
      Jan 30, 2023

      MDD Trial in London (MIJ821)

      Not yet recruiting
      • Major Depressive Disorder
      • London, United Kingdom
        Parexel Early Phase Clinical Unit (LONDON)
      Dec 18, 2022

      Dry Mouth, Xerostomia, Type 2 Diabetics Trial in Saint Louis (HA formulation Oral Spray, Placebo)

      Completed
      • Dry Mouth
      • +2 more
      • HA formulation Oral Spray
      • Placebo
      • Saint Louis, Missouri
        Division of Endocrinology and Metabolism, Saint Louis University
      Aug 9, 2021

      Investigate Adaptation and Evolution of Ovarian High-grade

      Recruiting
      • Ovarian Cancer
      • +6 more
        • Bristol, United Kingdom
        • +10 more
        Sep 8, 2022

        AAA, Abdominal Aortic Aneurysm, Blood Pressure Trial in London

        Recruiting
        • AAA
        • +2 more
          • London, United Kingdom
          • +1 more
          Aug 4, 2022

          Wrinkle, Periorbital, Tixel 2 Trial in Chicago, New York, Petach Tikva (Tixel 2)

          Completed
          • Wrinkle
          • +4 more
          • Tixel 2
          • Chicago, Illinois
          • +2 more
          May 17, 2022

          SARS-CoV-2 Trial in Spain, United Kingdom (Eicosapentaenoic acid gastro-resistant capsules, Placebo)

          Recruiting
          • SARS-CoV-2
          • Eicosapentaenoic acid gastro-resistant capsules
          • Placebo
          • Barcelona, Spain
          • +4 more
          Nov 26, 2021